From IPO to
Global Status Planning

Managing Partner

Alex Tian, Esq.

Xin (Alex) Tian is admitted in New York and California. He focuses on securities offerings (IPOs, SPACs, private placements), cross-border M&A, and premium immigration, including EB-5 investors, multinational executive transfers (L-1/EB-1C), and extraordinary ability cases. He counsels companies and investors raising capital, listing in the U.S., or structuring global asset allocations.

He holds an M.S. in Biology from New York University and a J.D., cum laude, from the University of Minnesota Law School (concentration in securities regulation, corporate governance, and international law), with further study at Harvard Kennedy School. Previously, he researched U.S. securities law at Thomson Reuters and consulted on electronic health records. He later served as Research Director at Beijing Qiansong Tech Development Co., Ltd., leading pharmaceutical acquisitions and cross-border tech licensing, earning two patents in data security and data sharing. He has published in IEEE venues and integrates biotech, data science, and law to design innovative, compliance-ready capital and immigration solutions.

• Admitted in New York and California; focuses on IPOs, SPACs, and cross-border M&A
• Builds high-end immigration strategies for EB-5, L-1/EB-1C executives, and extraordinary ability
• Data/biotech background as research director with two data security/sharing patents and IEEE publications